1. Home
  2. CLDI vs LMFA Comparison

CLDI vs LMFA Comparison

Compare CLDI & LMFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDI
  • LMFA
  • Stock Information
  • Founded
  • CLDI 2014
  • LMFA 2008
  • Country
  • CLDI United States
  • LMFA United States
  • Employees
  • CLDI N/A
  • LMFA N/A
  • Industry
  • CLDI Biotechnology: Biological Products (No Diagnostic Substances)
  • LMFA Finance: Consumer Services
  • Sector
  • CLDI Health Care
  • LMFA Finance
  • Exchange
  • CLDI Nasdaq
  • LMFA Nasdaq
  • Market Cap
  • CLDI 10.2M
  • LMFA 8.6M
  • IPO Year
  • CLDI N/A
  • LMFA 2015
  • Fundamental
  • Price
  • CLDI $0.23
  • LMFA $2.36
  • Analyst Decision
  • CLDI Strong Buy
  • LMFA Hold
  • Analyst Count
  • CLDI 1
  • LMFA 1
  • Target Price
  • CLDI $10.00
  • LMFA N/A
  • AVG Volume (30 Days)
  • CLDI 1.8M
  • LMFA 104.2K
  • Earning Date
  • CLDI 08-12-2025
  • LMFA 08-13-2025
  • Dividend Yield
  • CLDI N/A
  • LMFA N/A
  • EPS Growth
  • CLDI N/A
  • LMFA N/A
  • EPS
  • CLDI N/A
  • LMFA N/A
  • Revenue
  • CLDI N/A
  • LMFA $8,029,601.00
  • Revenue This Year
  • CLDI N/A
  • LMFA $0.98
  • Revenue Next Year
  • CLDI N/A
  • LMFA $4.31
  • P/E Ratio
  • CLDI N/A
  • LMFA N/A
  • Revenue Growth
  • CLDI N/A
  • LMFA N/A
  • 52 Week Low
  • CLDI $0.20
  • LMFA $1.02
  • 52 Week High
  • CLDI $3.89
  • LMFA $5.35
  • Technical
  • Relative Strength Index (RSI)
  • CLDI 21.13
  • LMFA 67.15
  • Support Level
  • CLDI $0.31
  • LMFA $1.62
  • Resistance Level
  • CLDI $0.33
  • LMFA $2.46
  • Average True Range (ATR)
  • CLDI 0.04
  • LMFA 0.18
  • MACD
  • CLDI -0.01
  • LMFA 0.05
  • Stochastic Oscillator
  • CLDI 14.83
  • LMFA 82.74

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

About LMFA LM Funding America Inc.

LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.

Share on Social Networks: